- Home
- CHPT vs ABSI Comparison
CHPT vs ABSI Comparison
Compare CHPT & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHPT
- ABSI
- Stock Information
- Founded
- CHPT 2007
- ABSI 2011
- Country
- CHPT United States
- ABSI United States
- Employees
- CHPT N/A
- ABSI N/A
- Industry
- CHPT Industrial Specialties
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- CHPT Consumer Discretionary
- ABSI Health Care
- Exchange
- CHPT Nasdaq
- ABSI Nasdaq
- Market Cap
- CHPT 340.1M
- ABSI 338.0M
- IPO Year
- CHPT N/A
- ABSI 2021
- Fundamental
- Price
- CHPT $11.29
- ABSI $2.39
- Analyst Decision
- CHPT Hold
- ABSI Strong Buy
- Analyst Count
- CHPT 10
- ABSI 5
- Target Price
- CHPT $29.13
- ABSI $7.98
- AVG Volume (30 Days)
- CHPT 532.9K
- ABSI 4.4M
- Earning Date
- CHPT 09-03-2025
- ABSI 08-12-2025
- Dividend Yield
- CHPT N/A
- ABSI N/A
- EPS Growth
- CHPT N/A
- ABSI N/A
- EPS
- CHPT N/A
- ABSI N/A
- Revenue
- CHPT $407,681,000.00
- ABSI $4,138,000.00
- Revenue This Year
- CHPT $2.79
- ABSI $44.71
- Revenue Next Year
- CHPT $24.20
- ABSI $374.26
- P/E Ratio
- CHPT N/A
- ABSI N/A
- Revenue Growth
- CHPT N/A
- ABSI 27.32
- 52 Week Low
- CHPT $8.55
- ABSI $2.01
- 52 Week High
- CHPT $39.20
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- CHPT 47.09
- ABSI 33.33
- Support Level
- CHPT $11.41
- ABSI $2.50
- Resistance Level
- CHPT $11.85
- ABSI $2.73
- Average True Range (ATR)
- CHPT 0.59
- ABSI 0.18
- MACD
- CHPT 0.08
- ABSI -0.04
- Stochastic Oscillator
- CHPT 39.55
- ABSI 1.94
About CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.